![Use of pharmacological treatment for posttraumatic stress disorder : Analysis of a psychiatric population in Switzerland and comparison with international guidelines [Traitement pharmacologique de l'état de stress post-traumatique : analyse d'une population en Suisse et comparaison avec les recommandations internationales]](https://bibliotheque.cpa01.fr/img_cache/pmb_cpa_record_1859.webp)
| Titre : | Use of pharmacological treatment for posttraumatic stress disorder : Analysis of a psychiatric population in Switzerland and comparison with international guidelines [Traitement pharmacologique de l'état de stress post-traumatique : analyse d'une population en Suisse et comparaison avec les recommandations internationales] (2023) |
| Auteurs : | MONTAVON F ; VANDENBERGHE FRÉDÉRIK ; EAP CB |
| Type de document : | Article |
| Dans : | ENCEPHALE (5 vol 49, 2023) |
| Article en page(s) : | 446-452 |
| Note générale : | Fig./25 réf. bibliogr. |
| Descripteurs |
[SANTEPSY] ANTICONVULSIVANT [SANTEPSY] ANTIDEPRESSEUR [SANTEPSY] ANTIPSYCHOTIQUE [SANTEPSY] BENZODIAZEPINE [SANTEPSY] RECOMMANDATION [SANTEPSY] SYNDROME POST TRAUMATIQUE [SANTEPSY] THERAPEUTIQUE MEDICAMENTEUSE |
| Mots-clés libres: | SUISSE |
| Résumé : | Objectives : Several international guidelines for the pharmacological treatment of posttraumatic stress disorder (PTSD) have been published. However, it is unclear whether clinicians use these procedures in their daily practice. We compared the psychopharmacological prescription patterns in a Swiss adult psychiatric center with international clinical guidelines at admission and discharge. Methods : Retrospective chart review study between 2005 and 2015 of adult patients with PTSD and no other documented psychiatric comorbidity. Results : Fifty-two outpatients and 21 inpatients were included; 47% had at least one psychopharmacological treatment at admission. Among them, 47% had one or several antidepressants, mainly escitalopram (31%, n = 5) or citalopram. At discharge, 68% had at least one psychopharmacological treatment. Among them, 76% had at least one antidepressant, mainly escitalopram (34%, n = 13) or mirtazapine (21%, n = 8). They were compared to the guidelines of the Department of Veterans Affairs and Department of Defense (VA/DoD), showing 19% of the patients treated with antidepressants at admission were in agreement with the guidelines (sertraline, fluoxetine, paroxetine, venlafaxine), and 26% at discharge. In addition, we found prescriptions of benzodiazepines (62% at admission and 50% at discharge), antipsychotics (12% and 22%), Z-drugs (zolpidem, zopiclone: 15 and 40%) and a few pregabalin prescriptions (n = 4). Conclusions : Clinicians in this study frequently prescribed antidepressants to treat PTSD, as recommended. However, most of the antidepressants used were not recommended in the VA/DoD guidelines. Benzodiazepines and Z-drugs remained widely used, although they are not recommended. [Résumé d'auteur] |
| En ligne : | https://www.em-premium.com/article/1621438 |
Bibliothèque Médicale et Professionnelle
Bibliothèque Médicale & Professionnelle
Accueil
Sélection de la langue
Se connecter
Adresse
Bibliothèque Médicale et Professionnelle04 74 52 28 07
contact
